This is where the clock is ticking loudly
According to the STEP 1 trial published in the New England Journal of Medicine , participants who combined semaglutide with lifestyle intervention achieved significantly greater weight loss than those on placebo with the same lifestyle program
Plateaus Are Normal: What to Expect: Initial rapid loss (first 3 months) Continued steady loss (months 4-12) Plateau period (months 13-18) Final adjustments (months 19-24) Plateaus dont mean failure: Natural part of weight loss Body adjusting to new weight May need dose optimization Continue medication to maintain loss Non-Scale Victories: Results Beyond the Number: Even if weight loss is slower than hoped, patients experience: Reduced waist circumference: Lost inches even when scale stalls Better blood pressure: 5-10 mmHg reduction common Improved blood sugar: A1C reductions of 1-2 points Better cholesterol: 10-20% improvement in lipids Increased energy: From weight loss and metabolic improvements Improved mobility: Easier movement, less joint pain Better sleep: Improvement in sleep apnea Enhanced quality of life: Confidence, mood, relationships These improvements matter regardless of exact pounds lost
Furthermore, this study adheres to the recommendations of the ARRIVE guidelines ( for the reporting of animal experiments
Vitamin C deficiency, high-sensitivity C-reactive protein, and cardiac event-free survival in patients with heart failure
The app does not interpret why the scale stalled that is a question for your clinician but it gives you a clearer picture to bring to the conversation
